Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer

Erstveröffentlichung

2017

Authors

Schramm, Amelie

Schochter, Fabienne

Friedl, Thomas W. P.

de Greqorio, Nikolaus

Andergassen, Ulrich

et al.

Wissenschaftlicher Artikel

Published in

Clinical Breast Cancer ; 17 (2017), 4. - S. 279-285. - ISSN 1526-8209. - eISSN 1938-0666

Link to publication

https://dx.doi.org/10.1016/j.clbc.2016.11.008

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Subject headings

[Free subject headings]: Adjuvant chemotherapy | Anthracyclines | Circulating tumor cells | HER2-negative early breast cancer | randomized-trial | premenopausal women | pooled analysis | her2 status | cyclophosphamide | fluorouracil | methotrexate | epirubicin | relevance | predicts
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record